Alrighty... Fresh coffee in hand Blue skies and sun is shining Booked meeting room Waiting patiently to read ANN Rethink strategy post ANN Let's go SAS!
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling